Measurement of impedance is becoming increasingly available in the clinical setting as a tool for assessing hemodynamics and volume status in patients with heart failure. The 2 major categories of impedance assessment are the band electrode method and the implanted device lead method. The exact sources of the impedance signal are complex and can be influenced by physiologic effects such as blood volume, fluid, and positioning. This article provides a critical review of our current understanding and promises of impedance measurements, the techniques that have evolved, as well as the evidence and limitations regarding their clinical applications in the setting of heart failure management.Beginning in the 1940s, there has been recognition that changes in impedance are related to pulsatile blood volume, 1 and the assessment of impedance has been explored in aerospace applications as measures of cardiac output and stroke volume to monitor in-flight physiology. 2,3 Over the past decades, refinement in impedance techniques has led to the development of diagnostic and prognostic tools in cardiovascular medicine. 4,5 With commercial development of diagnostic devices and add-on functionalities in implanted devices that measure impedance, there is increasing interest in the clinical applications of impedance measurements in the management of heart failure. This article reviews our current understanding and promises of impedance measurements, the techniques that have evolved, and the evidence and limitations regarding their clinical applications, with the focus on heart failure management.